PedAM
Pediatric Disease Annotations & Medicines
| Disease | pulmonary hypertension |
| Phenotype | C0206062|interstitial lung disease |
| Sentences | 20 |
| PubMedID- 24697923 | Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with pde-5 inhibitors. |
| PubMedID- 21613438 | Prediction of pulmonary hypertension in patients with or without interstitial lung disease: reliability of ct findings. |
| PubMedID- 26283756 | B-lines in assessment of pulmonary hypertension in patients with interstitial lung diseases: feasibility of transthoracic lung sonographic signs. |
| PubMedID- 25613108 | Role of bnp and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: an algorithm application model. |
| PubMedID- 21454061 | Conclusion: severe kco reduction is frequently related to pulmonary hypertension, especially when associated with emphysema and/or interstitial lung disease. |
| PubMedID- 21474572 | Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease. |
| PubMedID- 25378843 | [25] the prevalence of isolated pulmonary arterial hypertension and pulmonary hypertension with interstitial lung disease in systemic sclerosis were similar and ranged between 18 and 22% in various studies. |
| PubMedID- 22936711 | We assessed the safety, tolerability and preliminary efficacy of riociguat, a soluble guanylate cyclase stimulator, in patients with pulmonary hypertension associated with interstitial lung disease (ph-ild). |
| PubMedID- 23797369 | We tested whether sscpah or systemic sclerosis-related pulmonary hypertension with interstitial lung disease imposes a greater pulmonary vascular load than ipah and leads to worse rv contractile function. |
| PubMedID- 22415303 | Little is known regarding the cellular and molecular mechanisms that lead to pulmonary hypertension in patients with interstitial lung disease, and effective treatment options are lacking. |
| PubMedID- 23543646 | Treatment of pulmonary hypertension in interstitial lung disease: do not throw out the baby with the bath water. |
| PubMedID- 22425136 | pulmonary hypertension in interstitial lung disease: prevalence, prognosis and 6 min walk test. |
| PubMedID- 23271856 | We report a nigerian sickle cell patient who presented with computed tomography proven interstitial lung disease complicated by pulmonary hypertension and cor pulmonale. |
| PubMedID- 20920139 | The use of sildenafil to treat pulmonary hypertension associated with interstitial lung disease. |
| PubMedID- 21536179 | [pulmonary hypertension in interstitial lung diseases: diagnostic and therapeutic approach in 2011. |
| PubMedID- 21538327 | Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies. |
| PubMedID- 25183617 | We report the case of a 75-years-old man who diagnosed with severe pulmonary hypertension, associated with interstitial lung disease characterized by a rapid and fatal outcome. |
| PubMedID- 22054725 | Response to pulmonary vasodilator treatment in a former smoker with combined interstitial lung disease complicated by pulmonary hypertension: case report and review of the literature. |
| PubMedID- 21846759 | Ct detection of pulmonary hypertension in interstitial lung disease: the glass is half full. |
| PubMedID- 23034317 | Diagnostic and prognostic role of biomarkers for pulmonary hypertension in interstitial lung disease. |
Page: 1